Cornell Cancer & Oncology Research

80 recent oncology and cancer research papers authored by Cornell University faculty and affiliates, drawn from arXiv, newest first.

80 listed

• Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline, Version 2026.1.22026-08-17
  Manish A. Shah
  arXiv ↗
• A NON-CANONICAL ROLE FOR NOTCH3 IN BUILDING THE INTESTINAL LYMPHATIC NICHE2026-08-15
  Natasza A. Kurpios, Liqing Huang, Bhargav D. Sanketi, Madhav Mantri, YanXi Chen, Clare Wang, Tristan Tran, Iwijn De Vlaminck
  arXiv ↗
• Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications2026-08-13
  Caitlin Unkenholz, Alison Moskowitz, Santosha Vardhana
  arXiv ↗
• Bispecific CAR T for extramedullary myeloma: a minute waltz2026-08-13
  Hamza Hashmi, Sham Mailankody
  arXiv ↗
• Infectious complications following bispecific antibody or CAR T therapy in adult patients with hematologic malignancies: a retrospective database analysis2026-08-13
  Eleftherios Mylonakis
  arXiv ↗
• Next-Generation Immune Checkpoint Inhibitors in Gastrointestinal Cancers: Mechanisms, Resistance, and Emerging Therapeutic Strategies2026-08-12
  Abdullah Esmail
  arXiv ↗
• Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer2026-08-11
  Wungki Park
  arXiv ↗
• CAR T cell therapy beyond cancer: current status, challenges and future prospects2026-08-11
  Saurabh Upadhyay, Sungwoo Cho, Kirti Upmanyu, Moustafa T. Gabr
  arXiv ↗
• Immune Circuit Rewiring by HDAC Inhibition Enables Response to Dual Checkpoint Blockade in Metastatic Breast Cancer2026-08-11
  Vered Stearns
  arXiv ↗
• Multi-analyte liquid biopsy characterization of metastatic inflammatory breast cancer: comparison with non-inflammatory breast cancer2026-08-06
  Eleonora Nicolò, Letizia Pontolillo, Mara S. Serafini, Nadia Bayou, Brenno Pastò, Hunter Gaudio, Maroua Manai, Carolina Reduzzi, Massimo Cristofanilli
  arXiv ↗
• Weight Loss Responses to Pharmacotherapy in Breast Cancer Survivors: Results from the Adaptive Nutrition and Exercise Weight loss (A-NEW) Study2026-08-04
  Vered Stearns
  arXiv ↗
• A New Face in the Examination Room: Ethical Implications of Artificial Intelligence Chaperones in Dermatology2026-08-01
  Shari R. Lipner
  arXiv ↗
• Modeling the synovium on a chip for studying the interactions between lymphatic vasculature and synoviocytes in rheumatoid arthritis2026-07-31
  Samantha Kraus, Issahy Cano, Soo‐Jin Kim, Esak Lee
  arXiv ↗
• Robust CD4 ⁺ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma2026-07-29
  Sridevi Rajeeve, Alexander M. Lesokhin, Neha Korde, Carlyn Tan, Hamza Hashmi, Hani Hassoun, Kylee Maclachlan, Urvi A. Shah, Malin Hultcrantz, Maximilian Merz, F
  arXiv ↗
• Immune Checkpoint Activation Targeting PD-1H (VISTA) Reinforces Human T-Cell Tolerance in Autoimmunity 23350532026-07-28
  Ziwei Yang
  arXiv ↗
• Novel autochthonous cancer model to investigate TCR signal strength in tumor-specific T cell differentiation 23349052026-07-28
  Sandra Carson
  arXiv ↗
• Co-targeting Deregulated WNT and MAPK Signaling Pathways Limits Phenotypic Reprogramming of Intestinal Stem Cell Progeny in KRAS-Hyperactivated Colorectal Cancer2026-07-28
  Rona Yaeger
  arXiv ↗
• BCMA-directed CAR-T cell therapy induces durable drug-free remission in refractory primary immune thrombocytopenia2026-07-24
  James B. Bussel
  arXiv ↗
• Datopotamab deruxtecan versus chemotherapy in previously treated inoperable/metastatic hormone receptor-positive HER2-negative breast cancer: safety and patient-reported outcomes from the phase III TROPION-Breast01 study2026-07-24
  K. Jhaveri
  arXiv ↗
• Racial and ethnic disparities in brain-to-vein time among patients receiving CD19 CAR-T cell therapy for relapsed/refractory DLBCL2026-07-22
  Neil Easton, Anna Alperovich, Alexandra Gomez-Arteaga, Sebastian Mayer, Nora Chokr, Tsiporah B. Shore, Juliet Barker, Samuel Yamshon
  arXiv ↗
• Enteric Microbiome Features that Contribute to Gram-Negative Bloodstream Infections in Hematopoietic Cell Transplant Recipients Colonized with Fluoroquinolone-Resistant Enterobacterales2026-07-22
  Grace A. Maldarelli, Jamie Marino, John R. Lee, Lars F Westblade, Michael Hovan, Claire Douglass, Randy S Longman, Michael J. Satlin
  arXiv ↗
• 0062 Establishment of dermatopathology image data base DermpathNet using artificialIntelligence empowered workflow2026-07-21
  Y. Peng
  arXiv ↗
• Neoadjuvant Immune Therapy in Patients With Melanoma: Response and Toxicity in a Non‐Clinical Trial Setting2026-07-19
  Michael A. Postow
  arXiv ↗
• Extracellular vesicles isolated from frozen whole blood show biomarker potential in small intestine neuroendocrine neoplasms2026-07-14
  Linda Bojmar
  arXiv ↗
• MEK-dependent bioenergetic demand drives terminal CD8⁺ T cell exhaustion.2026-07-13
  Tanmana Mitra, Morgan Huse, Santosha A Vardhana
  arXiv ↗
• Comparing the Effectiveness and Safety of Different Third-Line Management Options for Patients with Metastatic Colorectal Cancer: A Systematic Review and Reconstructed Individual Patient Data Meta-Analysis2026-07-08
  Maen Abdelrahim, Abdullah Esmail
  arXiv ↗
• Immune Checkpoint Inhibitors are Associated With Increased Risk of Lichen Planus in a <scp>TriNetX</scp> Analysis2026-07-07
  Shari R. Lipner
  arXiv ↗
• Locus-specific HERV expression identifies an aggressive, NK-depleted, checkpoint-refractory acral melanoma phenotype2026-07-06
  Jez Marston, Tongyi Fei, Matthew L. Bendall, Douglas F. Nixon
  arXiv ↗
• OptiLITT: A Computer-Assisted Planning System for Dual-Fiber Laser Interstitial Thermal Therapy using Cylindrical Ablation Optimization2026-07-06
  Natalie Yeung
  arXiv ↗
• Colorectal cancers with distinct metastatic potential trigger divergent early T cell responses2026-07-04
  Sebastian E. Carrasco, Norihiro Goto
  arXiv ↗
• Anti–PD-(L)1 plus chemotherapy in advanced PD-L1–negative nonsquamous non-small cell lung cancer: a systematic review and meta-analysis2026-07-03
  Alexander Drilon
  arXiv ↗
• Abstract LT02: Aggressive B-cell lymphomas retain ATR-dependent determinants of T-cell exclusion from the Germinal Center Dark Zone2026-07-02
  Giovanni Medico, Maria V. Revuelta, Giorgio Inghirami, Leandro Cerchietti, Roberta Zappasodi
  arXiv ↗
• Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years2026-07-02
  Michael A. Postow
  arXiv ↗
• The clinical picture of ICANS after CAR-T cell therapy in critically ill patients: A retrospective clustering analysis of a multicentre multinational cohort study2026-07-01
  Sanjay Chawla
  arXiv ↗
• Environmentally induced cell stiffening shapes metastatic site selection by tuning the immune vulnerability of cancer cells2026-07-01
  Aliya Holland
  arXiv ↗
• Telling the Whole Story: The Ethics of Cherry-Picking Data in Dermatology2026-07-01
  Shari R. Lipner
  arXiv ↗
• 515P Immune-mediated adverse events (imAEs) in MATTERHORN: A phase III study of durvalumab (D) plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric/gastroesophageal junction (G/GEJ) adenocarcinoma2026-07-01
  D Molena, Y.Y. Janjigian
  arXiv ↗
• 652eTiP Ifinatamab deruxtecan as second or third-line therapy for advanced esophageal squamous cell carcinoma: Substudy 06F of the phase I/II KEYMAKER-U06 study2026-07-01
  M.A. Shah
  arXiv ↗
• Molecular dynamics driving phenotypic divergence among KRAS mutants in pancreatic tumorigenesis2026-07-01
  Adrien Grimont, David J. Falvo, Whitney J. Sisso, Francisco dos Santos, Christopher W. Chan, Paul Zumbo, William B. Fall, Katherine Ferrick, Grace Pan, Megan Cl
  arXiv ↗
• Pancreatic Cancer: Translating Tumor Biology into Actionability2026-07-01
  Fiyinfolu Balogun, Wungki Park, Eileen M. O’Reilly
  arXiv ↗
• Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer2026-07-01
  Roisin E. O’Cearbhaill
  arXiv ↗
• Healthcare resource utilization and economic burden of metastatic pancreatic cancer: a US commercial and Medicare claims analysis2026-07-01
  Kenneth H. Yu
  arXiv ↗
• 74531 Optimizing Access to Dermatologic Care: Impact of an Algorithmic Scheduling Strategy on New Patient Visit Lead Times2026-07-01
  Noelle Desir
  arXiv ↗
• 74692 Mapping the Evidence Landscape of Nail Unit Melanoma: A Scoping Review2026-07-01
  Shari Lipner
  arXiv ↗
• Who Writes the Note: The Training Data Behind Artificial Intelligence Scribes in Dermatology2026-07-01
  Shari R. Lipner
  arXiv ↗
• HIV Infection and Opioid Treatment Enable the Engraftment of Kaposi Sarcoma‐Like Tumors Into Immunocompetent Mice2026-06-29
  Anuj Ahuja, Ethel Cesarman
  arXiv ↗
• Multi-dimensional orchestration of binders for improved CAR-T immunotherapy2026-06-28
  Chaoyang Zhu, Z H Jiang, Rui Jing, Wei Guo, Yong Lu
  arXiv ↗
• Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities2026-06-26
  Hui–Hsuan Kuo, Bhavneet Bhinder, Hamza N. Gokozan, Kathryn Gorski, Pooja Chandra, Jyothi Manohar, Daniela Guevara, John Otilano, Jenna Moyer, Marvel Tranquille,
  arXiv ↗
• Langerhans cell control of early-life dermal lymphatic development shapes adult immunity2026-06-26
  Ji Hyun Sim, William Shipman, Niroshana Anandasabapathy, Lionel B. Ivashkiv, Theresa T. Lu
  arXiv ↗
• A Patient-Derived Xenograft Repository Capturing Clinical and Molecular Heterogeneity of Large B-cell Lymphoma2026-06-24
  Giorgio Inghirami
  arXiv ↗
• Abstract A017: A patient derived xenograft repository capturing clinical and molecular heterogeneity of large B-cell lymphoma2026-06-24
  Giorgio Inghirami
  arXiv ↗
• Immune checkpoint blockade augments lymphodepleting chemotherapy-induced antitumor immunity by expanding effector CD8+ T cell clones2026-06-22
  Mariam M. George, Linda Hamadene, Yacine Marouf, Daniel Hirschhorn, Lauren Dong, Divya Venkatesh, Rachana Maniyar, Sadna Budhu, Jedd D. Wolchok, Taha Merghoub
  arXiv ↗
• Generation of three induced pluripotent stem cell lines from an immune checkpoint inhibitor-induced myocarditis patient and controls2026-06-22
  Yuhsin Vivian Huang
  arXiv ↗
• Second Primary Malignant Neoplasms After T-Cell–Engaging Bispecific Antibody Therapy2026-06-18
  Saad Z. Usmani, Gilles Salles, Miguel-Angel Perales, Roni Shouval
  arXiv ↗
• Payers’ Views on Insurance Coverage for Confirmatory Diagnostics After a Noncovered Multicancer Early Detection (MCED) Test2026-06-18
  Mark Robson
  arXiv ↗
• CAR T cells take on precancers2026-06-17
  Sham Mailankody
  arXiv ↗
• Pan-cancer multi-omic integration of Trop2 reveals biological determinants and translational implications for ADC therapy2026-06-15
  Carlo Bosi
  arXiv ↗
• Associations of alcohol use with expression of stromal markers in benign breast biopsy samples2026-06-11
  Rulla M. Tamimi
  arXiv ↗
• Examining bidirectional longitudinal relationships between physical activity and physical function in older breast cancer survivors: The Thinking and Living with Cancer study2026-06-10
  Eunji Choi
  arXiv ↗
• Recent Trends in Race and Ethnicity Reporting in Breast Surgery Journals2026-06-10
  X Ma, Lisa Newman
  arXiv ↗
• The Diagnostic Utility of PRAME in a Case of Trans-Differentiated Melanoma Metastatic to the Heart2026-06-09
  Carla Stephan, José Jessurun
  arXiv ↗
• Benchmarking urinary cell transcriptomes for noninvasive differentiation of BK polyomavirus–associated nephropathy from T cell–mediated rejection2026-06-08
  Franco B. Mueller, Carol Li, Darshana M. Dadhania, Surya V. Seshan, Thalia Salinas, Vijay K. Sharma, JZ Xiang, Thangamani Muthukumar, Manikkam Suthanthiran
  arXiv ↗
• Preclinical discovery and clinical development of glofitamab in relapsed/ refractory large B-cell lymphomas2026-06-07
  Gilles Salles
  arXiv ↗
• Epithelial-mesenchymal transition and immunosuppression: Two sides of the same coin2026-06-06
  Brian Feng, Anushka Dongre
  arXiv ↗
• Recent Developments in the Diagnosis and Treatment of Disseminated and Rare Melanoma with Radiotheranostics2026-06-05
  Jason S. Lewis, Nagavarakishore Pillarsetty
  arXiv ↗
• Brief Review: Rethinking Colonic Redundancy in Gastroenterology2026-06-05
  Réka G. Szigeti, Eamonn M. M. Quigley
  arXiv ↗
• Novel technologies for gastrointestinal cancer detection: a systematic review and meta-analysis of diagnostic accuracy2026-06-04
  S A Alqahtani
  arXiv ↗
• Real-world treatment patterns of patients with large B-cell lymphoma over time and into a post–CAR T approval era2026-06-03
  Miguel-Angel Perales
  arXiv ↗
• Updated outcomes from STAMP: Surgically treated adjuvant Merkel cell carcinoma with pembrolizumab, a phase III trial—ECOG-ACRIN EA6174.2026-06-03
  Jedd D. Wolchok
  arXiv ↗
• Human expertise or artificial intelligence? A prospective study on nail disorder diagnosis2026-06-02
  Shari R. Lipner
  arXiv ↗
• Kidney Transplantation Post–Chimeric Antigen Receptor (CAR) T-Cell Therapy in Multiple Myeloma2026-06-01
  Zahraa Khan, Darshana M. Dadhania
  arXiv ↗
• Real-world assessment of prophylactic anakinra on neurotoxicity and cytokine release syndrome after CD19 CAR T-cell therapy in R/R B-cell lymphoma: An inverse probability of treatment weighting analysis2026-06-01
  Neil Easton, Mia Andreoli, Herman van Besien, Caitlin Gribbin, Michelle Pasciolla, Anna Alperovich, Mateo Mejía Saldarriaga, Barbara Ma, Nora Chokr, Amer Assal,
  arXiv ↗
• Durvalumab plus etoposide–platinum in patients with epidermal growth factor receptor (EGFR)-mutated advanced NSCLC and neuroendocrine transformation after first-line osimertinib: ORCHARD2026-06-01
  Helena A. Yu
  arXiv ↗
• Urinary Cell Transcriptome in BK Virus Nephropathy—Mechanistic Insights &amp; Precision Diagnostics2026-06-01
  F. Mueller, C. Li, D. Dadhania, S. Seshan, T. Salinas, V K Sharma, T. Muthukumar, M. Suthanthiran
  arXiv ↗
• Potravitug for the Treatment of BK Polyomavirus Infection in Kidney Transplant Recipients: A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial2026-06-01
  D. Dadhania
  arXiv ↗
• Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II Trials2026-06-01
  Ciara M. Kelly, Lauren B. Banks, Viswatej Avutu, Ping Chi, Sujana Movva, M. D. Dickson, Mrinal M. Gounder, Mary L. Keohan, Robert G. Maki, William D. Tap, Sandr
  arXiv ↗
• Exercise and Nutrition in Hematologic Malignancies: Translational Evidence and Emerging Interventions2026-06-01
  Francesca Castro, Urvi A. Shah
  arXiv ↗
• Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanoma2026-06-01
  James W. Smithy
  arXiv ↗
• Safety and outcomes of CD19 CAR-T cell therapy in splenectomized patients with B-cell lymphomas2026-06-01
  Roni Shouval
  arXiv ↗
• Practical Guide to Address Common Myths in the Pre- and Post-kidney Transplant Management of the Elderly Patient with Cancer: An Opinion Paper.2026-06-01
  Darshana M Dadhania
  arXiv ↗